BGFIGIQZFXXTQE-QWENJRSESA-N
C36H49F3N6O5 — CID 154618098
Data last refreshed: (MolForge compound catalog, from PubChem)
About BGFIGIQZFXXTQE-QWENJRSESA-N
BGFIGIQZFXXTQE-QWENJRSESA-N (PubChem CID 154618098) has the molecular formula C36H49F3N6O5 and a molecular weight of 702.82 g/mol. Its IUPAC name is (2S,3S)-3-cyclohexyl-2-[[2,2-difluoro-2-(6-methoxy-3-pyridinyl)acetyl]amino]-N-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]butanamide.
Molecular Properties
| Compound Name | BGFIGIQZFXXTQE-QWENJRSESA-N |
|---|---|
| PubChem CID | 154618098 |
| Molecular Formula | C36H49F3N6O5 |
| Molecular Weight | 702.82 g/mol |
| Exact Mass | 702.37 |
| IUPAC Name | (2S,3S)-3-cyclohexyl-2-[[2,2-difluoro-2-(6-methoxy-3-pyridinyl)acetyl]amino]-N-[2-fluoro-4-[(2S,3R)-4-(4-methylpiperazin-1-yl)-4-oxo-3-(propanoylamino)butan-2-yl]phenyl]butanamide |
| SMILES | CCC(=O)N[C@@H](C(=O)N1CCN(C)CC1)[C@@H](C)c1ccc(NC(=O)[C@@H](NC(=O)C(F)(F)c2ccc(OC)nc2)[C@@H](C)C2CCCCC2)c(F)c1 |
| InChI | InChI=1S/C36H49F3N6O5/c1-6-29(46)42-32(34(48)45-18-16-44(4)17-19-45)23(3)25-12-14-28(27(37)20-25)41-33(47)31(22(2)24-10-8-7-9-11-24)43-35(49)36(38,39)26-13-15-30(50-5)40-21-26/h12-15,20-24,31-32H,6-11,16-19H2,1-5H3,(H,41,47)(H,42,46)(H,43,49)/t22-,23-,31-,32+/m0/s1 |
| InChIKey | BGFIGIQZFXXTQE-QWENJRSESA-N |
| XLogP | 4.43 |
| TPSA | 132.97 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 13 |
| Heavy Atoms | 50 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 702.82 |
| LogP ≤ 5 | 4.43 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 154618098 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.